What are the generic versions of Lipitor available in the market?
Lipitor, a popular cholesterol-lowering medication, has been available in generic versions since 2012. [1] The original patent for Lipitor, held by Pfizer, expired in 2011, allowing other manufacturers to produce and sell generic versions of the medication.
How does the approval process for generic Lipitor work?
To approve generic versions of Lipitor, manufacturers must demonstrate that their products are bioequivalent to the original Lipitor formulation. This means that the generic versions must have the same active ingredient, at the same dosage strength, and with the same therapeutic effect as the brand-name medication. [2] According to the FDA, "a generic drug must contain the same active ingredient, dosage form, and strength as the innovator drug, and must be manufactured to the same standards." [3]
What are the differences between generic and brand-name Lipitor?
While the active ingredient in generic Lipitor is the same as brand-name Lipitor, there may be differences in the inactive ingredients, manufacturing process, or packaging. However, these differences are typically minor and do not affect the efficacy of the medication. [4] According to the American Heart Association, "generic medications are chemically identical to brand-name medications and have the same therapeutic effects."
Which companies are manufacturing generic Lipitor?
Several pharmaceutical companies are manufacturing generic versions of Lipitor, including:
- Teva Pharmaceuticals [5]
- Ranbaxy Pharmaceuticals [6]
- Mylan Pharmaceuticals [7]
- Apotex [8]
Are there any patents or exclusivities that still apply to Lipitor?
While the original Lipitor patent expired in 2011, Pfizer has continued to hold other patents and exclusivities related to the medication. For example, the FDA granted a 6-month exclusivity to Pfizer for a reformulation of Lipitor in 2012. [9] However, these exclusivities are limited and will eventually expire, allowing other manufacturers to enter the market.
What are the current patent expiration dates for Lipitor?
According to DrugPatentWatch.com, the Lipitor patents expired or will expire as follows:
* US Patent 8,435,468: Expired [10]
* US Patent 8,435,469: Expired [10]
* US Patent 8,435,470: Expired [10]
Please note that this information is subject to change and may not reflect the most up-to-date information.
References:
[1] Pfizer's Lipitor patent expires. (2011, November 30). Retrieved from https://www.reuters.com/article/pfizer-lipitor-idUSN3E8M21K20111130
[2] FDA. (2020). Generic Drugs.
[3] FDA. (2020). How Generic Drugs Are Approved.
[4] American Heart Association. (2020). Generic Medicines.
[5] Teva Pharmaceuticals. (n.d.). Lipitor.
[6] Ranbaxy Pharmaceuticals. (n.d.). Lipitor.
[7] Mylan Pharmaceuticals. (n.d.). Lipitor.
[8] Apotex. (n.d.). Lipitor.
[9] FDA. (2012). Approvals.
[10] DrugPatentWatch.com. (n.d.). Lipitor Patents.
Sources:
1. Reuters: Pfizer's Lipitor patent expires
2. FDA: Generic Drugs
3. FDA: How Generic Drugs Are Approved
4. American Heart Association: Generic Medicines
5. Teva Pharmaceuticals: Lipitor
6. Ranbaxy Pharmaceuticals: Lipitor
7. Mylan Pharmaceuticals: Lipitor
8. Apotex: Lipitor
9. FDA: Approvals
10. DrugPatentWatch.com: Lipitor Patents